Loading data
DLBNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 1.35 bn USD | 1.27 bn USD | 1.3 bn USD | 1.25 bn USD |
| Cost of revenue | 160.13 m USD | 140.5 m USD | 152.57 m USD | 141.36 m USD |
| Gross profit | 1.19 bn USD | 1.13 bn USD | 1.15 bn USD | 1.11 bn USD |
| Research and development expense | 261.79 m USD | 263.66 m USD | 271.52 m USD | 261.17 m USD |
| Operating profit | 264.96 m USD | 258.33 m USD | 215.75 m USD | 206.61 m USD |
| Interest expense | — | — | — | 394 k USD |
| Profit before tax | 303.49 m USD | 312.48 m USD | 250.05 m USD | 215.28 m USD |
| Income tax expense | 46.99 m USD | 48.16 m USD | 48.41 m USD | 31.38 m USD |
| Net income (reported basis) | 256.49 m USD | 264.32 m USD | 201.64 m USD | 183.9 m USD |
| Basic earnings per share | 2.66 USD/share | 2.74 USD/share | 2.1 USD/share | 1.84 USD/share |
| Diluted earnings per share | 2.62 USD/share | 2.69 USD/share | 2.05 USD/share | 1.81 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.